HTG MOLECULAR DIAGNOSTICS IN
Historical 13F Holders
CUSIP
40434H203
All holders as of
Q3 2022
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2022 Q3
20
464 k
$283 k
$0
2022 Q2
23
606 k
$622 k
$0
2022 Q1
23
2.30 M
$3.19 M
$0
2021 Q4
24
2.68 M
$14.5 M
$0
2021 Q3
24
2.88 M
$16.4 M
$0
2021 Q2
26
3.40 M
$19.7 M
$0
2021 Q1
24
2.12 M
$11.2 M
$0
2020 Q4
23
1.53 M
$7.33 M
$0